LOCATION: CAMBRIDGE

Do you want to be at the cutting edge of innovation that will lead to a cure for cancer? At AstraZeneca, our team is working to make this a reality by bringing together our world-leading oncology pipeline with emerging innovations and technologies.
We are seeking a scientifically minded leader who is passionate about innovation in Oncology to join AstraZeneca’s Oncology R&D Search and Evaluation group. AstraZeneca has grown to be a leader in Oncology through bold decisions in both our internal pipeline as well as business development. We aim to expand our leadership by leveraging external innovation and building strong scientific networks.
The Executive Director of Search & Evaluation, Global Business Development & Licensing, Oncology R&D, is a leadership role in the Oncology R&D Strategy, Business Development & Licensing organization at AstraZeneca. In this role, you will support global business development and licensing initiatives and has a direct impact on the success of the Oncology R&D strategy and portfolio. The S&E group is responsible for proactively scouting external innovation to augment AstraZeneca Discovery, Early and Late Oncology R&D. By assembling teams of internal specialists, you will conduct due diligence activities that ensure an understanding of investment opportunities.
By effectively synthesizing and communicating the merits of potential investment opportunities, you will enable enterprise decision-making to ensure that Oncology R&D science, capabilities and project portfolio are fit for future challenges and opportunities.

The successful candidate will have a strong R&D scientific and clinical background, proven project and people leadership, business and strategic acuity and interpersonal skills. In addition, the ability to engage and collaborate across organizational boundaries with an entrepreneurial demeanor by acting with urgency and agility.

• Establish and drive the BD strategy for core strategic build areas within AZ Oncology, aligning with internal business partners and ensuring BD is embedded within the overall strategy
• Coach and mentor Senior Director S&E team members, developing and embedding outstanding practices
• Preparing and communicating Snr executive level reports of ongoing BD priorities
• Point of contact and triage for Search and evaluation of external opportunities emanating from academia, VC, biotech and peer-pharma including early research projects, new modality platforms, clinical stage candidates and Life Cycle Management opportunities for our pipeline assets and franchises that can improve the scientific credibility of AZ’s Oncology R&D portfolio
• Form and lead Cross-Functional Due Diligence teams and processes (for preclinical and early clinical assets) to drive detailed scientific evaluation of assets and deliver recommendations to governance bodies including the Senior Executive Management Team.
• Providing evaluation input and support for mid to late clinical Due Diligence assessments (with ongoing studies capable of achieving registration) when led from within the Business Development Operations DD team.
• Primary contact with the external partner throughout the deal process including during submission and negotiation of non-binding term sheet (NBTS) through to deal execution.
• Works collaboratively with the Transactional lead within the Oncology BD team during negotiation of any NBTS or definitive agreement.
• Leads the preparation and presentation of business case and other materials for senior management briefings with support from the R&D or BDO Transactions lead for transactional items
• Representing Oncology R&D’s critical initiatives and business priorities with senior management of the external life sciences community
• Best represents AstraZeneca’s scientific excellence through a deep understanding of the portfolio and ensures AZ is considered partner of choice.
• Deep specialised knowledge of industry trends in oncology including maintaining current awareness of competitor datasets in AZ areas of strategic focus

BASIC QUALIFICATIONS:

• Bachelor’s degree with 10 plus years of experience in evaluating opportunities OR
• Master’s degree with 8 plus years of experience OR
• PhD degree with 5 plus years of experience

PREFERRED QUALIFICATIONS:

• Highly experienced and skilled deal maker with a broad and extensive track record
• Recognised credibility with external companies, institutions and partners
• PhD, M.D., or M.D./PhD in oncology or a related scientific field
• Expert knowledge of commercial and financial evaluation and case preparation
• Extensive deal experience and solid foundation of generally accepted BD practices.
• Strong scientific reputation in drug discovery and development.
• Ability to interact and communicate effectively with senior executive teams.
• History of building internal/external relationships, demonstrating cultural sensitivity and awareness.
• Extensive experience in pharmaceutical R&D, demonstrating international experience in multiple cultures and drug discovery / clinical environments.
• Ability to think critically, creatively and to anticipate and solve problems.
• Ability to navigate and be successful in a fast-paced, highly matrixed work environment.

Please refer the Job description for details